CASP3 and urinary bladder cancer: As a result of the dCasRx-SINEB2 targeting PTEN, it was found that both bladder cancer cells significantly more frequently underwent cell death when the cell apoptosis was examined using caspase-3 and ELISA (Figure 6C).